Citation:
Koskinas J, Deutsch M, Ioannidou P, Manolakopoulos S, Cholongitas E, Rigopoulou EI, Schina MJ, Sevastianos VA, Elefsiniotis LS, Goulis J, et al. Efficacy and safety of direct acting antiviral (s)(DAA) containing regimens in the treatment of chronic hepatitis C (CHC) patients with genotype 3. A real life experience. In: Hepatology. Vol. 63. WILEY-BLACKWELL 111 RIVER ST, HOBOKEN 07030-5774, NJ USA; 2016. pp. 1007A–1008A. Copy at http://www.tinyurl.com/2363tpqj